Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy Partnership

▴ Max Healthcare
This innovative approach not only offers advanced therapeutic options to cancer patients but also addresses the affordability and accessibility challenges associated with life-saving treatments. As healthcare continues to evolve, partnerships like these pave the way for a brighter and more inclusive future in the fight against cancer.

In a groundbreaking move, Max Healthcare has launched CAR-T cell therapy at its Delhi NCR hospital in partnership with ImmunoACT, an IIT Bombay-incubated company. This therapy, known as a 'living drug,' represents a significant leap in the commitment to providing cutting-edge care for cancer patients. The collaboration with ImmunoACT allows for the sourcing of CAR-T cells, with the recent approval from the Central Drugs Standard Control Organisation (CDSCO) for its CAR-T cell therapy product in India.
 
Revolutionary CAR-T Therapy: CAR-T cell therapy stands as a revolutionary approach in cancer treatment, offering enduring benefits to patients with relapsed/refractory B-cell lymphomas and leukaemia. Dr. Harit K Chaturvedi, Chairman, Max Institute of Cancer Care, emphasized the innovative nature of CAR-T therapy, stating that it reflects Max Healthcare's continuous endeavor to push the boundaries of cancer treatment.
 
What is CAR-T Therapy: CAR-T therapy, or Chimeric Antigen Receptor T-cell therapy, is an innovative and personalized form of cancer treatment. In this therapy, a patient's own T cells (a type of immune system cell) are collected and genetically modified to express a receptor called a chimeric antigen receptor (CAR) on their surface. The CAR is designed to recognize specific proteins on the surface of cancer cells. Once the T cells are modified, they are multiplied in the laboratory and infused back into the patient. The engineered CAR-T cells can then seek out and attack cancer cells that express the targeted protein. CAR-T therapy has shown remarkable success, especially in treating certain types of blood cancers like B-cell lymphomas and leukaemia. It represents a significant approach to cancer treatment, offering a highly targeted and potent method to combat cancer cells in a patient's body. However, it's worth noting that CAR-T therapy is a complex and specialized treatment, and its application may be limited to certain cancer types and conditions.
 
Advantages of CAR-T Therapy: Also known as a 'living drug,' CAR-T therapy provides lasting benefits, making it a recommended option for individuals who cannot undergo a stem cell transplant or those experiencing post-transplant relapse. In contrast to traditional therapies, CAR-T therapy requires a brief, single-infusion treatment, significantly improving the quality of life for patients with an average of two weeks of in-patient care.
 
Significance of the Launch: Dr. Esha Kaul, Director – Haemato-Oncology/Bone Marrow Transplant at Max Super Speciality Hospital, highlighted the importance of this pathbreaking therapy in reinforcing their commitment to delivering personalized and effective solutions. The therapy aligns with the evolving healthcare landscape, contributing to the overall well-being and positive outcomes for patients under their care.
 
Affordable Access to Life-Saving Treatment: Shirish Arya, Co-founder, and Director – Strategy & Business Development at ImmunoACT, emphasized that the indigenously-developed CAR-T therapy will provide patients in India and countries with limited resources access to this life-saving drug at an affordable cost. This achievement positions the country on the world map of advanced cell-and-gene therapies.
 
The introduction of CAR-T cell therapy at Max Healthcare, in collaboration with ImmunoACT, signifies a major milestone in the field of cancer treatment in India. This innovative approach not only offers advanced therapeutic options to cancer patients but also addresses the affordability and accessibility challenges associated with life-saving treatments. As healthcare continues to evolve, partnerships like these pave the way for a brighter and more inclusive future in the fight against cancer.

Tags : #maxhealthcare #CART #ImmunoACT #cancertreatment #canncerawareness #cancerpatients #IITbombay #livingdrug #medicircle

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

FLO organised a unique program at Bansilalpet Step-wellMarch 01, 2024
Dr Raj Nagarkar Achieves Milestone As India's 1st & World’s 3rd Oncosurgeon To Perform Robotic Lobectomy With VersiusMarch 01, 2024
IIIT Hyderabad receives grant from Qualcomm to fund and support Edge AI ResearchMarch 01, 2024
FORSYS Inc opens new office in financial districtFebruary 29, 2024
The Rise in Patients Requiring Revision Hip Replacement SurgeryFebruary 29, 2024
Aakash Launches Study Material in BengaliFebruary 29, 2024
Harmony in Action: Nisarg Srishti's Dual Impact Initiative Unleashes a Symphony of Change at Sane Guruji Shikshan Sanshtha, Pragati VidyalayaFebruary 29, 2024
Wearable Tech in the Bedroom: Introducing Loop, MyMuse’s Vibrating Ring Massager for MenFebruary 28, 2024
TechInvention Lifecare announces the ground breaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures February 28, 2024
Endocrine Disorders: Causes, Tests And TreatmentFebruary 28, 2024
Çelebi Delhi Cargo Terminal Management Bolsters Security and Efficiency with "CargoCEL," Barcode Scanning UpgradeFebruary 28, 2024
Venkaiah Naidu unveiled a book “There I Was” authored by Mrs Aruna Ravi KumarFebruary 27, 2024
Maxivision Super Specialty Eye Hospitals introduces Schwind Amaris 500, a state-of-the-art German InnovationFebruary 27, 2024
Maximising circular economy strategies for rare earth elements supplyFebruary 27, 2024
FICCI Ladies Organization organised an interaction with one of the doyens of the Indian IT industry Dr BVR Mohan ReddyFebruary 27, 2024
Nat Habit strengthens leadership to accelerate its growth journey to 500 Cr; onboards Ankita Srivastava (ex-L’Oreal, Reckitt, Marico, Raymond Consumer Care) as Chief Marketing OfficerFebruary 27, 2024
Shiprocket Launches Aarambh 2024 for Women-Led SMEs NationwideFebruary 27, 2024
Treatment is prevention: Stop the spread of infection by finding all and treating all TBFebruary 27, 2024
Advancing Healthcare Access: ScreenHer initiative in Pakistan close to reaching milestone of 20,000 diabetes screenings in 70 clinics February 26, 2024
FICCI Ladies Organization organized an interaction with one of the doyens of Indian IT industry Dr BVR Mohan ReddyFebruary 26, 2024